Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia

Bone Marrow Transplant. 1991:7 Suppl 2:6-8.

Authors

C D Buckner¹, R A Clift, F R Appelbaum, R Storb, F B Petersen, J E Sanders, E D Thomas, J A Hansen

Affiliation

¹ Fred Hutchinson Cancer Research Center, Seattle, WA 98104.

PMID: 1878723

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Bone Marrow Transplantation / methods*
Cyclophosphamide / administration & dosage
Cyclosporins / administration & dosage
Graft vs Host Disease / mortality
Graft vs Host Disease / prevention & control
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery*
Leukemia, Myeloid, Acute / mortality
Leukemia, Myeloid, Acute / surgery*
Life Tables
Methotrexate / administration & dosage
Radiotherapy Dosage
Survival Analysis
Transplantation, Homologous
Washington / epidemiology
Whole-Body Irradiation

Substances

Cyclosporins
Cyclophosphamide
Methotrexate